Literature DB >> 19258183

Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.

Isao Nishimori1, Makoto Otsuki.   

Abstract

Autoimmune pancreatitis (AIP) is a unique form of chronic pancreatitis characterised by a high serum IgG4 concentration and complications that include various extrapancreatic manifestations, one of which is sclerosing cholangitis. In AIP patients, infiltration of abundant IgG4-positive plasma cells and dense fibrosis are commonly observed in the pancreas and wall of the bile duct and gallbladder. The major symptom at onset of AIP is obstructive jaundice caused by stricture of the bile duct, and this requires differential diagnosis of AIP from pancreato-biliary malignancies and primary sclerosing cholangitis (PSC). Recently, there have been reports of particular cases of sclerosing cholangitis with a high serum IgG4 level and cholangiographic and pathological findings comparable to those observed in AIP patients. Being apparently different from PSC and similar to that in AIP, sclerosing cholangitis with and without AIP shows a clinical response to steroid therapy and thus is designated as 'IgG4-associated sclerosing cholangitis'. The pathogenesis of AIP and IgG4-associated sclerosing cholangitis remains at yet undetermined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258183     DOI: 10.1016/j.bpg.2008.11.017

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  9 in total

1.  Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity.

Authors:  Seth Sweetser; David A Ahlquist; Neal K Osborn; Schuyler O Sanderson; Thomas C Smyrk; Suresh T Chari; Lisa A Boardman
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

2.  Immunoglobulin g4-associated autoimmune cholangiopathy.

Authors:  Keith D Lindor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

3.  Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife.

Authors:  Monica M Dua; Motaz Qadan; Glen A Lutchman; Walter G Park; George Triadafilopoulos; Brendan C Visser
Journal:  Dig Dis Sci       Date:  2014-08-20       Impact factor: 3.199

4.  IgG4-related systemic sclerosing disease: a diagnosis to be considered!!

Authors:  Bobby V M Dasari; Kevin McElvanna; Maurice Loughrey; Tom Diamond
Journal:  BMJ Case Rep       Date:  2013-03-28

5.  Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumor.

Authors:  Cindy Neuzillet; Céline Lepère; Mostafa El Hajjam; Laurent Palazzo; Monique Fabre; Hajer Turki; Pascal Hammel; Philippe Rougier; Emmanuel Mitry
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

6.  IgG4-related disease and the current status of diagnostic approaches.

Authors:  Haitao Du; Yinqiao Wu; Li Yan; Benyan Wu; Jun Wan
Journal:  EXCLI J       Date:  2012-09-17       Impact factor: 4.068

7.  Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis.

Authors:  Jin Imai; Hitoshi Ichikawa; Motoki Kaneko; Hiroyuki Ito; Shinji Takashimizu; Takayuki Shirai; Takuma Tajiri; Norihito Watanabe; Hidekazu Suzuki
Journal:  Case Rep Gastroenterol       Date:  2022-02-07

8.  Should Steroid Therapy Be Necessarily Needed for Autoimmune Pancreatitis Patients with Lesion Resected due to Misdiagnosed or Suspected Malignancy?

Authors:  Wenchuan Wu; Xiuzhong Yao; Chao Lin; Dayong Jin; Dansong Wang; Wenhui Lou; Xinyu Qin
Journal:  Gastroenterol Res Pract       Date:  2014-01-22       Impact factor: 2.260

9.  Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease.

Authors:  Kuang-Hui Yu; Tien-Ming Chan; Ping-Han Tsai; Ching-Hui Chen; Pi-Yueh Chang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.